GlassScriptPhysician profile
Duc T Nguyen
NPI 1437193026
$21,204.85
in general payments reported to CMS, 2019-2025
37 companies · $5,070 in 2025
The $5,070 reported for 2025 was more than what 83% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,504 · 2020: $1,219 · 2021: $2,749 · 2022: $1,733 · 2023: $766 · 2024: $6,164 · 2025: $5,070.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,993 · Travel and Lodging: $5,006.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,992.90 |
| Travel and Lodging | $5,006.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $5,273.62 | 2019-2025 | Impella |
| Medtronic, INC. | $3,503.84 | 2021-2025 | Onyx Frontier, Linq II, Symplicity G3 |
| Boston Scientific Corporation | $3,456.55 | 2019-2025 | Avvigo Guidance System, Emerge Push, Watchman Access System |
| Edwards Lifesciences Corporation | $2,639.98 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $1,243.21 | 2019-2025 | Ensite, Aveir, Jot Dx |
| Biotronik INC. | $752.10 | 2019-2025 | Amvia Edge, Biomonitor, Renamic Neo |
| Shockwave Medical, INC | $649.59 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $444.30 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $394.03 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $376.00 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $277.22 | 2019-2023 | Camzyos |
| Cathworks, INC. | $259.83 | 2024-2025 | Ffrangio |
| Siemens Medical Solutions USA, INC. | $242.34 | 2023-2024 | Artis Icono Biplane |
| Daiichi Sankyo INC. | $201.03 | 2021-2022 | |
| Cvrx, INC. | $178.27 | 2025 | Barostim Neo System |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $153.82 | 2019 | |
| Esperion Therapeutics, INC. | $133.88 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $132.84 | 2019 | |
| Bridgebio Pharma, INC. | $117.47 | 2025 | Attruby |
| Zoll Circulation INC | $116.85 | 2021 | |
| Biosense Webster, INC. | $104.93 | 2025 | Soundstar, Carto 3 |
| Novartis Pharmaceuticals Corporation | $101.95 | 2019-2024 | |
| Pfizer INC. | $73.04 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $58.37 | 2019 | |
| Stryker Corporation | $55.21 | 2025 | Flowtriever, Artix Mt |
| Medtronic Vascular, INC. | $50.44 | 2019-2020 | |
| Lundbeck LLC | $30.46 | 2019 | |
| Convatec INC. | $26.04 | 2019 | |
| Akcea Therapeutics, INC. | $23.22 | 2019 | |
| Irhythm Technologies, INC. | $22.23 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.85 | 2025 | |
| Lantheus Medical Imaging, INC. | $18.36 | 2019 | |
| Atricure, INC. | $16.68 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $15.25 | 2019 | |
| Astellas Pharma US INC | $13.97 | 2019 | |
| Philips North America LLC | $13.64 | 2021 | |
| Chiesi USA, INC. | $12.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Duc Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.